PGRMC1 and hepatocellular carcinoma: Our analysis revealed increased expression of CCM3 (Figure 6(B-1)) and PAQR5/7/9 (Figure 6(B-3)), while decreased expression of PGRMC1/2 (Figure 6(B-2)) demonstrated significantly worse prognostic outcomes in HCC patients.